| Product Code: ETC13249656 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Drug Discovery Outsourcing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Drug Discovery Outsourcing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Drug Discovery Outsourcing Market - Industry Life Cycle |
3.4 North America Drug Discovery Outsourcing Market - Porter's Five Forces |
3.5 North America Drug Discovery Outsourcing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Drug Discovery Outsourcing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Molecule, 2021 & 2031F |
3.8 North America Drug Discovery Outsourcing Market Revenues & Volume Share, By Discovery Approach, 2021 & 2031F |
3.9 North America Drug Discovery Outsourcing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.10 North America Drug Discovery Outsourcing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.11 North America Drug Discovery Outsourcing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 North America Drug Discovery Outsourcing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Drug Discovery Outsourcing Market Trends |
6 North America Drug Discovery Outsourcing Market, 2021 - 2031 |
6.1 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Chemical Services, 2021 - 2031 |
6.1.3 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Biology Services, 2021 - 2031 |
6.2 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Drug Molecule, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Small Molecules, 2021 - 2031 |
6.2.3 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Large Molecules, 2021 - 2031 |
6.3 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Discovery Approach, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Empirical Drug Discovery, 2021 - 2031 |
6.3.3 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Rational Drug Discovery, 2021 - 2031 |
6.4 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Workflow, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Target Identification and Screening, 2021 - 2031 |
6.4.3 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Lead Identification and Candidate Optimization, 2021 - 2031 |
6.4.4 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Development of Disease Models, 2021 - 2031 |
6.4.5 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Pre-formulation Studies, 2021 - 2031 |
6.4.6 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Entire Clinical Trials, 2021 - 2031 |
6.4.7 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Anti-infective, 2021 - 2031 |
6.5.3 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Cardiovascular, 2021 - 2031 |
6.5.4 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Central Nervous System, 2021 - 2031 |
6.5.5 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Dermatology, 2021 - 2031 |
6.5.6 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Endocrine, 2021 - 2031 |
6.5.7 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Gastrointestinal, 2021 - 2031 |
6.5.8 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Genitourinary System, 2021 - 2031 |
6.5.9 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Drug Discovery Outsourcing Market, Revenues & Volume, By End-user, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.6.3 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Biotechnology Companies, 2021 - 2031 |
6.6.4 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Academic Institutes, 2021 - 2031 |
7 North America Drug Discovery Outsourcing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Drug Discovery Outsourcing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Drug Discovery Outsourcing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Drug Discovery Outsourcing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Molecule, 2021 & 2031F |
7.3.1 United States (US) Drug Discovery Outsourcing Market, Revenues & Volume, By Drug Molecule, 2021 - 2031 |
7.3.2 Canada Drug Discovery Outsourcing Market, Revenues & Volume, By Drug Molecule, 2021 - 2031 |
7.3.3 Rest of North America Drug Discovery Outsourcing Market, Revenues & Volume, By Drug Molecule, 2021 - 2031 |
7.4 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Discovery Approach, 2021 - 2031 |
7.4.1 United States (US) Drug Discovery Outsourcing Market, Revenues & Volume, By Discovery Approach, 2021 - 2031 |
7.4.2 Canada Drug Discovery Outsourcing Market, Revenues & Volume, By Discovery Approach, 2021 - 2031 |
7.4.3 Rest of North America Drug Discovery Outsourcing Market, Revenues & Volume, By Discovery Approach, 2021 - 2031 |
7.5 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.1 United States (US) Drug Discovery Outsourcing Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.2 Canada Drug Discovery Outsourcing Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.3 Rest of North America Drug Discovery Outsourcing Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.6 North America Drug Discovery Outsourcing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.1 United States (US) Drug Discovery Outsourcing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.2 Canada Drug Discovery Outsourcing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.3 Rest of North America Drug Discovery Outsourcing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.7 North America Drug Discovery Outsourcing Market, Revenues & Volume, By End-user, 2021 - 2031 |
7.7.1 United States (US) Drug Discovery Outsourcing Market, Revenues & Volume, By End-user, 2021 - 2031 |
7.7.2 Canada Drug Discovery Outsourcing Market, Revenues & Volume, By End-user, 2021 - 2031 |
7.7.3 Rest of North America Drug Discovery Outsourcing Market, Revenues & Volume, By End-user, 2021 - 2031 |
8 North America Drug Discovery Outsourcing Market Key Performance Indicators |
9 North America Drug Discovery Outsourcing Market - Export/Import By Countries Assessment |
10 North America Drug Discovery Outsourcing Market - Opportunity Assessment |
10.1 North America Drug Discovery Outsourcing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Drug Discovery Outsourcing Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Molecule, 2021 & 2031F |
10.4 North America Drug Discovery Outsourcing Market Opportunity Assessment, By Discovery Approach, 2021 & 2031F |
10.5 North America Drug Discovery Outsourcing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10.6 North America Drug Discovery Outsourcing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10.7 North America Drug Discovery Outsourcing Market Opportunity Assessment, By End-user, 2021 & 2031F |
11 North America Drug Discovery Outsourcing Market - Competitive Landscape |
11.1 North America Drug Discovery Outsourcing Market Revenue Share, By Companies, 2022 |
11.2 North America Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here